DOCSLIB.ORG

Features and Further Application Related to L2HGA

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Features and Further Application Related to L2HGA 月 17, 2018 17:30 CST Features and Further Application Related to L2HGA L-2-hydroxyglutarate dehydrogenase is a mitochondrial enzyme in humans that is encoded by the L2HGDH gene on chromosome 14. This protein is a spotlight for research because of its clinical significance. Mutations in the L2HGDH gene cause L-2-hydroxyglutaric aciduria, which is a rare autosomal recessive neuro-metabolic disorder. Toxic accumulation of high concentration of L-2-hydroxyglutaric acid in the plasma and cerebrospinal fluid are discovered in individuals with L2HGDH mutations. Moreover, the researcher has discovered that patients with L-2- hydroxyglutaric aciduria (L2HGA) also present neurological symptoms and characteristic neuro-radiological findings, especially subcortical white matter abnormalities. After adopting the genotype-first approach of the whole exome sequence, compound heterozygous mutations of L2HGDH was discovered. The sample investigated was an adult patient with intellectual disability and epilepsy. A retrospective assay was also used to prove the concentrations of 2-hydroxyglutaric acid in the urine did increase. These findings taken together indicated that neuro-radiological findings of subcortical white matter abnormalities are features of L2HGA(the disease caused by abnormality in L2HGDH), moreover, clinical exome sequencing plays a role in compensating for gene expression clinical evaluations. Researcher also studied that whether L-2-HGA could provoke DNA oxidative damage in blood leukocytes and whether L-carnitine (LC) could prevent this kind of in vitro DNA damage. Researcher discovered that a certain amount (30 μM) of L-2-HG significantly induced DNA damage. However, this kind of damage is effectively prevented by 30 and 150 μM of LC. Oxidative stress parameters in urine of L-2-HGA patients were also observed. Investigator discovered that oxidized guanine species and di-tyrosine increase significantly. This indicated increase in oxidative DNA and protein damage. This data again proved that the presence of oxidative damage on DNA and protein in patients is affected by these diseases, and LC can prevent that from happening. In order to test the feasibility to measure in vivo the intracerebral levels of 2HG by using magnetic resonance spectroscopy (MRS), researcher used at 3T H 1-MRS Single-Voxel (SV) PRESS sequences tailored to detect 2HG, in three adult patients with the diagnosis of L2HGA along with healthy controls. These findings suggest that brain 2HG using MRS can play a role in the diagnosis and follow-up of L2HGA, additional to circulating plasma/serum 2HG levels by mass spectrometric assays. Investigator produced L2HGDH knockout (KO) mice and observed a considerable increase of L-2-hydroxyglutarate (L-2-HG) levels in multiple tissues. The highest levels of L-2-HG appeared in the brain and testis, coupled with an increase in histone methylation in these tissues. White matter abnormalities, extensive gliosis, microglia-mediated neuro- inflammation, along with an expansion of oligodendrocyte progenitor cells (OPCs) were also discovered in L2HGDH KO mice. What’s more, impairment of adult hippocampal neurogenesis and late-onset neurodegeneration in mouse brains has also been linked with L2HGDH. These data provide in vivo evidence that L2HGDH mutation leads to L-2-HG accumulation, leukoencephalopathy, and neurodegeneration in mice, offering new thoughts into the pathophysiology of L-2-HGA in humans. Using a metabolomics approach, researcher was able to identify elevations of the metabolite 2- hydroxyglutarate (2-HG) in the most common histology of kidney cancer, among the most common malignancies in both men and women. After adopting subsequent analysis, the predominant enantiomer of 2-HG elevated in renal cancer was proved to be the L(S) form. Increase of L- 2HG are considered due in part to loss of expression of the L2HGDH. These findings suggest that metabolites may play a role in tumor development and/or progression, which is similarly to oncogenes and oncoproteins. An integrated CRO company that provides a full range of drug development services, including Molecular Biology, Biochemistry, Systems Biology, Organic Chemistry, Genomics, Bioinformatics, Structural Biology, Preclinical and Clinical studies..
Load more

Recommended publications
  • Identification and Characterization of TPRKB Dependency in TP53 Deficient Cancers
    Identification and Characterization of TPRKB Dependency in TP53 Deficient Cancers. by Kelly Kennaley A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy (Molecular and Cellular Pathology) in the University of Michigan 2019 Doctoral Committee: Associate Professor Zaneta Nikolovska-Coleska, Co-Chair Adjunct Associate Professor Scott A. Tomlins, Co-Chair Associate Professor Eric R. Fearon Associate Professor Alexey I. Nesvizhskii Kelly R. Kennaley [email protected] ORCID iD: 0000-0003-2439-9020 © Kelly R. Kennaley 2019 Acknowledgements I have immeasurable gratitude for the unwavering support and guidance I received throughout my dissertation. First and foremost, I would like to thank my thesis advisor and mentor Dr. Scott Tomlins for entrusting me with a challenging, interesting, and impactful project. He taught me how to drive a project forward through set-backs, ask the important questions, and always consider the impact of my work. I’m truly appreciative for his commitment to ensuring that I would get the most from my graduate education. I am also grateful to the many members of the Tomlins lab that made it the supportive, collaborative, and educational environment that it was. I would like to give special thanks to those I’ve worked closely with on this project, particularly Dr. Moloy Goswami for his mentorship, Lei Lucy Wang, Dr. Sumin Han, and undergraduate students Bhavneet Singh, Travis Weiss, and Myles Barlow. I am also grateful for the support of my thesis committee, Dr. Eric Fearon, Dr. Alexey Nesvizhskii, and my co-mentor Dr. Zaneta Nikolovska-Coleska, who have offered guidance and critical evaluation since project inception.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Teleological Role of L-2-Hydroxyglutarate
    © 2020. Published by The Company of Biologists Ltd | Disease Models & Mechanisms (2020) 13, dmm045898. doi:10.1242/dmm.045898 RESEARCH ARTICLE Teleological role of L-2-hydroxyglutarate dehydrogenase in the kidney Garrett Brinkley1, Hyeyoung Nam1, Eunhee Shim1,*, Richard Kirkman1, Anirban Kundu1, Suman Karki1, Yasaman Heidarian2, Jason M. Tennessen2, Juan Liu3, Jason W. Locasale3, Tao Guo4, Shi Wei4, Jennifer Gordetsky5, Teresa L. Johnson-Pais6, Devin Absher7, Dinesh Rakheja8, Anil K. Challa9 and Sunil Sudarshan1,10,‡ ABSTRACT insight into the physiological role of L2HGDH as well as mechanisms L-2-hydroxyglutarate (L-2HG) is an oncometabolite found elevated in that promote L-2HG accumulation in disease states. renal tumors. However, this molecule might have physiological roles that extend beyond its association with cancer, as L-2HG levels are KEY WORDS: L-2-hydroxyglutarate, L-2-hydroxyglutarate dehydrogenase, TCA cycle, PPARGC1A elevated in response to hypoxia and during Drosophila larval development. L-2HG is known to be metabolized by L-2HG dehydrogenase (L2HGDH), and loss of L2HGDH leads to elevated INTRODUCTION L-2HG levels. Despite L2HGDH being highly expressed in the kidney, Oncometabolites are small molecules that have been found elevated its role in renal metabolism has not been explored. Here, we report our in various malignancies. To date, these molecules include the findings utilizing a novel CRISPR/Cas9 murine knockout model, with tricarboxylic acid (TCA) cycle intermediates succinate and fumarate a specific focus on the role of L2HGDH in the kidney. Histologically, as well as both enantiomers of 2-hydroxyglutarate (D-2HG and L2hgdh knockout kidneys have no demonstrable histologic L-2HG) (Tomlinson et al., 2002; Baysal et al., 2000; Niemann and abnormalities.
    [Show full text]
  • Enzyme DHRS7
    Toward the identification of a function of the “orphan” enzyme DHRS7 Inauguraldissertation zur Erlangung der Würde eines Doktors der Philosophie vorgelegt der Philosophisch-Naturwissenschaftlichen Fakultät der Universität Basel von Selene Araya, aus Lugano, Tessin Basel, 2018 Originaldokument gespeichert auf dem Dokumentenserver der Universität Basel edoc.unibas.ch Genehmigt von der Philosophisch-Naturwissenschaftlichen Fakultät auf Antrag von Prof. Dr. Alex Odermatt (Fakultätsverantwortlicher) und Prof. Dr. Michael Arand (Korreferent) Basel, den 26.6.2018 ________________________ Dekan Prof. Dr. Martin Spiess I. List of Abbreviations 3α/βAdiol 3α/β-Androstanediol (5α-Androstane-3α/β,17β-diol) 3α/βHSD 3α/β-hydroxysteroid dehydrogenase 17β-HSD 17β-Hydroxysteroid Dehydrogenase 17αOHProg 17α-Hydroxyprogesterone 20α/βOHProg 20α/β-Hydroxyprogesterone 17α,20α/βdiOHProg 20α/βdihydroxyprogesterone ADT Androgen deprivation therapy ANOVA Analysis of variance AR Androgen Receptor AKR Aldo-Keto Reductase ATCC American Type Culture Collection CAM Cell Adhesion Molecule CYP Cytochrome P450 CBR1 Carbonyl reductase 1 CRPC Castration resistant prostate cancer Ct-value Cycle threshold-value DHRS7 (B/C) Dehydrogenase/Reductase Short Chain Dehydrogenase Family Member 7 (B/C) DHEA Dehydroepiandrosterone DHP Dehydroprogesterone DHT 5α-Dihydrotestosterone DMEM Dulbecco's Modified Eagle's Medium DMSO Dimethyl Sulfoxide DTT Dithiothreitol E1 Estrone E2 Estradiol ECM Extracellular Membrane EDTA Ethylenediaminetetraacetic acid EMT Epithelial-mesenchymal transition ER Endoplasmic Reticulum ERα/β Estrogen Receptor α/β FBS Fetal Bovine Serum 3 FDR False discovery rate FGF Fibroblast growth factor HEPES 4-(2-Hydroxyethyl)-1-Piperazineethanesulfonic Acid HMDB Human Metabolome Database HPLC High Performance Liquid Chromatography HSD Hydroxysteroid Dehydrogenase IC50 Half-Maximal Inhibitory Concentration LNCaP Lymph node carcinoma of the prostate mRNA Messenger Ribonucleic Acid n.d.
    [Show full text]
  • Supplementary Materials
    Supplementary Materials COMPARATIVE ANALYSIS OF THE TRANSCRIPTOME, PROTEOME AND miRNA PROFILE OF KUPFFER CELLS AND MONOCYTES Andrey Elchaninov1,3*, Anastasiya Lokhonina1,3, Maria Nikitina2, Polina Vishnyakova1,3, Andrey Makarov1, Irina Arutyunyan1, Anastasiya Poltavets1, Evgeniya Kananykhina2, Sergey Kovalchuk4, Evgeny Karpulevich5,6, Galina Bolshakova2, Gennady Sukhikh1, Timur Fatkhudinov2,3 1 Laboratory of Regenerative Medicine, National Medical Research Center for Obstetrics, Gynecology and Perinatology Named after Academician V.I. Kulakov of Ministry of Healthcare of Russian Federation, Moscow, Russia 2 Laboratory of Growth and Development, Scientific Research Institute of Human Morphology, Moscow, Russia 3 Histology Department, Medical Institute, Peoples' Friendship University of Russia, Moscow, Russia 4 Laboratory of Bioinformatic methods for Combinatorial Chemistry and Biology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow, Russia 5 Information Systems Department, Ivannikov Institute for System Programming of the Russian Academy of Sciences, Moscow, Russia 6 Genome Engineering Laboratory, Moscow Institute of Physics and Technology, Dolgoprudny, Moscow Region, Russia Figure S1. Flow cytometry analysis of unsorted blood sample. Representative forward, side scattering and histogram are shown. The proportions of negative cells were determined in relation to the isotype controls. The percentages of positive cells are indicated. The blue curve corresponds to the isotype control. Figure S2. Flow cytometry analysis of unsorted liver stromal cells. Representative forward, side scattering and histogram are shown. The proportions of negative cells were determined in relation to the isotype controls. The percentages of positive cells are indicated. The blue curve corresponds to the isotype control. Figure S3. MiRNAs expression analysis in monocytes and Kupffer cells. Full-length of heatmaps are presented.
    [Show full text]
  • Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
    Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase
    [Show full text]
  • Metabolic Features of Mouse and Human Retinas: Rods Vs
    bioRxiv preprint doi: https://doi.org/10.1101/2020.07.10.196295; this version posted July 11, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Metabolic features of mouse and human retinas: rods vs. cones, macula vs. periphery, retina vs. RPE Bo Li1,2&, Ting Zhang3&, Wei Liu4,5, Yekai Wang1, Rong Xu1, Shaoxue Zeng3, Rui Zhang3, Siyan Zhu1, Mark C Gillies3, Ling Zhu3, Jianhai Du1* Running title: Metabolic features in human and mouse retinas 1Departments of Ophthalmology and Biochemistry, West Virginia University, Morgantown, WV 26506 2Department of Ophthalmology, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, 225100, Jiangsu Province, China 3Save Sight Institute, Sydney Medical School, University of Sydney, Sydney, NSW 2000, Australia 4Department of Ophthalmology and Visual Sciences, Albert Einstein College of Medicine, Bronx, NY 10461 5Department of Genetics, Albert Einstein College of Medicine, Bronx, NY 10461 &These authors contributed equally to this work. Corresponding Author: Jianhai Du, One Medical Center Dr, PO Box 9193, WVU Eye Institute, Morgantown, WV 26505; Phone: (304)-598-6903; Fax: (304)-598-6928; Email: [email protected]. Keywords: Retinal metabolism; macula; periphery; cone photoreceptors; nutrient Abbreviations: AC-Gly: Acetyl-Glycine; Ala: Alanine; Arg: Arginine; Asn: Asparagine; Asp: Aspartate; BAIBA: β-aminoisobutyric acid; β-Ala: β-alanine; C2: Acetylcarnitine; C3:
    [Show full text]
  • Two Novel L2HGDH Mutations Identified in a Rare Chinese Family
    Peng et al. BMC Medical Genetics (2018) 19:167 https://doi.org/10.1186/s12881-018-0675-9 CASE REPORT Open Access Two novel L2HGDH mutations identified in a rare Chinese family with L-2- hydroxyglutaric aciduria Wei Peng1,2,3†, Xiu-Wei Ma1,2,3†, Xiao Yang1,2,3, Wan-Qiao Zhang1,2,3, Lei Yan1,2,3, Yong-Xia Wang1,2,3, Xin Liu1,2,3, Yan Wang1,2,3* and Zhi-Chun Feng1,2,3* Abstract Background: L-2-Hydroxyglutaric aciduria (L-2-HGA) is a rare organic aciduria neurometabolic disease that is inherited as an autosomal recessive mode and have a variety of symptoms, such as psychomotor developmental retardation, epilepsy, cerebral symptoms as well as increased concentrations of 2-hydroxyglutarate (2-HG) in the plasma, urine and cerebrospinal fluid. The causative gene of L-2-HGA is L-2-hydroxyglutarate dehydrogenase gene (L2HGDH), which consists of 10 exons. Case presentation: We presented a rare patient primary diagnosis of L-2-HGA based on the clinical symptoms, magnetic resonance imaging (MRI), and gas chromatography-mass spectrometry (GC-MS) results. Mutational analysis of the L2HGDH gene was performed on the L-2-HGA patient and his parents, which revealed two novel mutations in exon 3: a homozygous missense mutation (c.407 A > G, p.K136R) in both the maternal and paternal allele, and a heterozygous frameshift mutation [c.407 A > G, c.408 del G], (p.K136SfsX3) in the paternal allele. The mutation site p.K136R of the protein was located in the pocket of the FAD/NAD(P)-binding domain and predicted to be pathogenic.
    [Show full text]
  • Structure, Substrate Specificity, and Catalytic Mechanism of Human D-2
    Yang et al. Cell Discovery (2021) 7:3 Cell Discovery https://doi.org/10.1038/s41421-020-00227-0 www.nature.com/celldisc ARTICLE Open Access Structure, substrate specificity, and catalytic mechanism of human D-2-HGDH and insights into pathogenicity of disease-associated mutations Jun Yang1,HanwenZhu1, Tianlong Zhang1 and Jianping Ding 1,2 Abstract D-2-hydroxyglutarate dehydrogenase (D-2-HGDH) catalyzes the oxidation of D-2-hydroxyglutarate (D-2-HG) into 2- oxoglutarate, and genetic D-2-HGDH deficiency leads to abnormal accumulation of D-2-HG which causes type I D-2- hydroxyglutaric aciduria and is associated with diffuse large B-cell lymphoma. This work reports the crystal structures of human D-2-HGDH in apo form and in complexes with D-2-HG, D-malate, D-lactate, L-2-HG, and 2-oxoglutarate, respectively. D-2-HGDH comprises a FAD-binding domain, a substrate-binding domain, and a small C-terminal domain. The active site is located at the interface of the FAD-binding domain and the substrate-binding domain. The functional roles of the key residues involved in the substrate binding and catalytic reaction and the mutations identified in D-2- HGDH-deficient diseases are analyzed by biochemical studies. The structural and biochemical data together reveal the molecular mechanism of the substrate specificity and catalytic reaction of D-2-HGDH and provide insights into the pathogenicity of the disease-associated mutations. 1234567890():,; 1234567890():,; 1234567890():,; 1234567890():,; Introduction hydroxybutyrate to succinate semialdehyde coupled with 2-Hydroxyglutarate (2-HG) is a low-abundance meta- the reduction of 2-OG to D-2-HG9,10.
    [Show full text]
  • Perkinelmer Genomics to Request the Saliva Swab Collection Kit for Patients That Cannot Provide a Blood Sample As Whole Blood Is the Preferred Sample
    Autism and Intellectual Disability TRIO Panel Test Code TR002 Test Summary This test analyzes 2429 genes that have been associated with Autism and Intellectual Disability and/or disorders associated with Autism and Intellectual Disability with the analysis being performed as a TRIO Turn-Around-Time (TAT)* 3 - 5 weeks Acceptable Sample Types Whole Blood (EDTA) (Preferred sample type) DNA, Isolated Dried Blood Spots Saliva Acceptable Billing Types Self (patient) Payment Institutional Billing Commercial Insurance Indications for Testing Comprehensive test for patients with intellectual disability or global developmental delays (Moeschler et al 2014 PMID: 25157020). Comprehensive test for individuals with multiple congenital anomalies (Miller et al. 2010 PMID 20466091). Patients with autism/autism spectrum disorders (ASDs). Suspected autosomal recessive condition due to close familial relations Previously negative karyotyping and/or chromosomal microarray results. Test Description This panel analyzes 2429 genes that have been associated with Autism and ID and/or disorders associated with Autism and ID. Both sequencing and deletion/duplication (CNV) analysis will be performed on the coding regions of all genes included (unless otherwise marked). All analysis is performed utilizing Next Generation Sequencing (NGS) technology. CNV analysis is designed to detect the majority of deletions and duplications of three exons or greater in size. Smaller CNV events may also be detected and reported, but additional follow-up testing is recommended if a smaller CNV is suspected. All variants are classified according to ACMG guidelines. Condition Description Autism Spectrum Disorder (ASD) refers to a group of developmental disabilities that are typically associated with challenges of varying severity in the areas of social interaction, communication, and repetitive/restricted behaviors.
    [Show full text]
  • Molecular Genetic Studies of Canine Inherited Diseases Including Sams, Neuronal Ceroid Lipofuscinosis and Dilated Cardiomyopathy
    MOLECULAR GENETIC STUDIES OF CANINE INHERITED DISEASES INCLUDING SAMS, NEURONAL CEROID LIPOFUSCINOSIS AND DILATED CARDIOMYOPATHY A Dissertation presented to the Faculty of the Graduate School University of Missouri In Partial Fulfillment Of the Requirements for the Degree Doctor of Philosophy in Genetics by Douglas H. Gilliam, Jr. Dr. Gary S. Johnson, Dissertation Supervisor May 2016 The undersigned, appointed by the Dean of the Graduate School, have examined the dissertation entitled MOLECULAR GENETIC STUDIES OF CANINE INHERITED DISEASES INCLUDING SAMS, NEURONAL CEROID LIPOFUSCINOSIS AND DILATED CARDIOMYOPATHY Presented by Douglas Howard Gilliam, Jr. a candidate for the degree of Doctor of Philosophy in Genetics and hereby certify that in their opinion it is worthy of acceptance Dr. Gary S. Johnson Dr. James Amos-Landgraf Dr. Dennis Lubahn Dr. Dennis O’Brien Dr. Bimal Ray ACKNOWLEDGEMENTS I would like to take this chance to give my unending appreciation to everyone that had a hand in my reaching this goal. I would like to thank Dr. Gary Johnson who believed in me when others didn’t and always had a kind word and an open door when they were needed. I would also like to thank the rest of my committee members, Dr. James Amos-Landgraf, Dr. Dennis O’Brien, Dr. Dennis Lubahn and Dr. Bimal Ray; your knowledge and assistance with this work and others would made this possible. I deeply thank you for all you’ve done and it was a fantastic experience working with all of you. Thanks also to Dr. Joan Coates, Dr. Stacey Leach and Dr. Martin Katz for assistance with several projects, including those found within this dissertation.
    [Show full text]
  • D-2-Hydroxyglutarate Produced by Mutant IDH2 Causes Cardiomyopathy and Neurodegeneration in Mice
    Downloaded from genesdev.cshlp.org on October 3, 2021 - Published by Cold Spring Harbor Laboratory Press D-2-hydroxyglutarate produced by mutant IDH2 causes cardiomyopathy and neurodegeneration in mice Esra A. Akbay,1,2,3 Javid Moslehi,4,5 Camilla L. Christensen,1,2,3 Supriya Saha,2,6 Jeremy H. Tchaicha,1,2,3 Shakti H. Ramkissoon,1,2,7 Kelly M. Stewart,8 Julian Carretero,9 Eiki Kikuchi,1,3,3 Haikuo Zhang,1,2,3 Travis J. Cohoon,1,3 Stuart Murray,8 Wei Liu,8 Kazumasa Uno,10 Sudeshna Fisch,10 Kristen Jones,11 Sushma Gurumurthy,12 Camelia Gliser,8 Sung Choe,8 Marie Keenan,8 Jaekyoung Son,2,13 Illana Stanley,14 Julie A. Losman,1,2 Robert Padera,7 Roderick T. Bronson,15 John M. Asara,16 Omar Abdel-Wahab,17 Philip C. Amrein,6 Amir T. Fathi,5 Nika N. Danial,2,14 Alec C. Kimmelman,13 Andrew L. Kung,18 Keith L. Ligon,1,2,6 Katharine E. Yen,8 William G. Kaelin Jr.,1,2 Nabeel Bardeesy,2,6 and Kwok-Kin Wong1,2,3,12,19 1–18[Author affiliations appear at the end of the paper.] Mutations in isocitrate dehydrogenase 1 and 2 (IDH1/2) have been discovered in several cancer types and cause the neurometabolic syndrome D2-hydroxyglutaric aciduria (D2HGA). The mutant enzymes exhibit neomorphic activity resulting in production of D2-hydroxyglutaric acid (D-2HG). To study the pathophysiological conse- quences of the accumulation of D-2HG, we generated transgenic mice with conditionally activated IDH2R140Q and IDH2R172K alleles.
    [Show full text]